AREA UNDER THE CURVE;
BODY WEIGHT;
BONE MARROW TRANSPLANTATION;
CHILD;
CHILD CARE;
CLINICAL PROTOCOL;
DOSE CALCULATION;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG DOSE REGIMEN;
ENZYME METABOLISM;
HUMAN;
LETTER;
PRIORITY JOURNAL;
UPREGULATION;
Population pharmacokinetics of busulfan in children: Increased evidence for body surface area and allometric body weight dosing of busulfan in children
Trame MN, Bergstrand M, Karlsson MO, Boos J, Hempel G. Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children. Clin Cancer Res 2011;17:6867-77.
Pharmacokinetic behaviour and appraisal of intravenous busulfan dosing in infants and older children: The results of a population pharmacokinetic study from a large paediatric cohort undergoing hematopoietic stem cell transplantation
Paci A, Vassal G, Moshous D, Dalle JH, Bleyzac N, Neven B, et al. Pharmacokinetic behaviour and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large paediatric cohort undergoing hematopoietic stem cell transplantation. Ther Drug Monit 2012;34:198-208.
Screening for potential covariates influencing the pharmacokinetics of intravenous busulfan: Results from a large pediatric cohort undergoing hematopoietic stem-cell transplantation
abstract. Abstract nr 1811
Daher Abdi Z, Paci A, Moshous D, Dalle JH, Bleyzac N, Neven B, et al. Screening for potential covariates influencing the pharmacokinetics of intravenous busulfan: results from a large pediatric cohort undergoing hematopoietic stem-cell transplantation [abstract]. In: Proceedings of the 53rd Annual Meeting and Exposition of ASH; 2010 Dec 10-13. Orange County, CA. 2010. Abstract nr 1811.
Optimizing the busulfan dosing regimen to get a more predictable exposure: A data driven analysis
Bartelink IH, Boelens JJ, Bredius RGM, Egberts ACG, Biering M, Shaw P, et al. Optimizing the busulfan dosing regimen to get a more predictable exposure: a data driven analysis. Biol Blood Marrow Transplant 2011;17:S180.
EBMT/ESID guidelines for haematopoietic stem cell transplantation for primary immunodeficiencies
EBMT, ESID
EBMT, ESID. EBMT/ESID guidelines for haematopoietic stem cell transplantation for primary immunodeficiencies. In: Proceedings of the 15th Biennial Meeting of the European Society for Immunodeficiencies. 2010.
